Gene transfer by adeno-associated virus vectors into the central nervous system

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 113-124

  Xiao, Xiao ^a   Li, Juan ^a   McCown, Thomas J ^a,b   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; GENE TRANSFER; IMMUNE RESPONSE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031104792     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6396     Document Type: Article

References (81)

1. 1. AFIONE, S. A., C. K. CONRAD, W. G. KEARNS, S. CHUNDURU, R. ADAMS, T. REYNOLDS, W. B. GUGGINO, G. R. CUTTING, B. J. CARTER, AND T. R. FLOTTE. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70: 3235-3241.
2. 2. ALEXANDER, I. E., D. W. RUSSELL, AND A. D. MILLER. 1994. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68: 8282-8287.
3. 3. ALEXANDER, I. E., D. W. RUSSELL, A. M. SPENCE, AND A. D. MILLER. 1996. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7: 841-850.
4. 4. BARTLETT, J. S., X. XIAO, AND R. J. SAMULSKI. 1996. Adeno-associated virus vectors for gene transfer. Pages 115-127 in P. R. Lowenstein and L. W. Enquist, Eds., Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. Wiley, Chichester.
5. 5. BASKAR, J. F., P. P. SMITH, G. NILAVER, R. A. LUPP, S. HOFFMANN, N. J. PEFFER, D. J. TENNEY, A. M. COLBERG-POLEY, P. GHAZAL, AND J. A. NELSON. 1996. The enhancer domain of human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
6. 6. BAUDARD, M., T. R. FLOTTE, J. M. ARAN, A. R. THIERRY, I. PASTAN, M.-G. PANG, W. G. KEARNS, AND M. M. GOTTESMAN. 1996. Expression of the human multidrug resistance and glucocerebrosidase cDNA from adeno-associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes. Hum. Gene Ther. 7: 1309-1322.
7. 7. BERNS, K. I., AND R. A. BOHENZKY. 1987. Adeno-associated viruses: An update. Adv. Virus Res. 32: 243-306. [Review]
8. 8. BERNS, K. I., AND C. GIRAUD. 1995. Adenovirus and adeno-associated virus as vectors for gene therapy. Ann. N. Y. Acad. Sci. 772: 95-104.
9. 9. BERNS, K. I., AND R. M. LINDEN. 1995. The cryptic life style of adeno-associated virus. Bioessays 17: 237-245.
10. 10. BERNS, K. I., AND R. M. LINDEN. 1995. The cryptic life style of adeno-associated virus. Bioessays 17: 237-245. [Review]
11. 11. BYRNES, A. P., R. E. MACLAREN, AND H. M. CHARLTON. 1996. Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflamation, reduced gene expression, and demyelination. J. Neurosci. 16: 3045-3055.
12. 12. BYRNES, A. P., J. E. RUSBY, M. J. A. WOOD, AND H. M. CHARLTON. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66: 1015-1024.
13. 13. CHEUNG, A. K., M. D. HOGGAN, W. W. HAUSWIRTH, AND K. I. BERNS. 1980. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33: 739-748.
14. 14. CLARK, K. R., F. VOULGAROPOULOU, D. M. FRALEY, AND P. R. JOHNSON. 1995. Cell lines for the production of adeno-associated virus. Hum. Gene Ther. 6: 1329-1341.
15. 15. DOLL, R. F., J. E. CRANDALL, C. A. DYER, J. M. AUCOIN, AND F. I. SMITH. 1996. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther. 3: 437-447.
16. 16. DURING, M., Z. ZENG, R. KAUL, F. SORGI, L. HUANG, E. MEE, J. WANG, L. MAYES, L. MENT, AND P. LEONE. 1996. Gene therapy for Canavan disease. Soc. Neurosci. Abstr. 18.12.
17. 17. DURING, M. J., D. CHOI-LUNDBERG, P. LEONE, Q. LIN, M. G. KAPLITT, X. XIAO, R. J. SAMULSKI, A. FREESE, P. HOFFER, R. H. ROTH, J. D. ELSWORTH, J. R. SLADEK JR., K. L. O'MALLEY, H. J. FEFEROFF, D. E. REDMOND JR., AND M. C. BOHN. 1995. Neuroprotection and neuroregeneration in rodent and primate Parkinsonian models using AAV vectors expressing GDNF Soc. Neurosci. Abstr. 21: 542.
18. 18. DURING, M. J., R. J. SAMULSKI, J. D. ELSWORTH, M. G. KAPLITT, P. LEONE, X. XIAO, J. LI, A. FREESE, J. R. TAYLOR, R. H. ROTH, J. R. SLADEK JR., K. L. O'MALLEY, AND D. E. REDMOND JR. 1996. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Submitted for publication.
19. 19. DURING, M. J., Z. ZENG, E. WALLACE, P. LEONE, AND R. S. SHERWIN. 1996. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Submitted for publication.
20. 20. EINERHAND, M. P., M. ANTONIOU, S. ZOLOTUKHIN, N. MUZYCZKA, K. I. BERNS, F. GROSVELD, AND D. VALERIO. 1995. Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther. 2: 336-343.
21. 21. FERRARI, F. K., T. SAMULSKI, T. SHENK, AND R. J. SAMULSKI. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70: 3227-3234.
22. 22. FISHER, K. J., G. P. GAO, M. D. WEITZMAN, R. DEMATTEO, J. F. BURDA, AND J. M. WILSON. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70: 520-532.
23. + human hematopoietic progenitor cells after transduction. Blood 88: 492-504.
24. 24. FLOTTE, T., B. CARTER, C. CONARD, W. GUGGINO, T. REYNOLDS, B. ROSENSTEIN, G. TAYLOR, S. WALDEN, AND R. WETZEL. 1996. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7: 1145-1159.
25. 25. FLOTTE, T. R., S. A. AFIONE, C. CONRAD, S. A. MCGRATH, R. SOLOW, H. OKA, P. L. ZEITLIN, W. B. GUGGINO, AND B. J. CARTER 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90: 10613-10617.
26. 26. FLOTTE, T. R., S. A. AFIONE, R. SOLOW, M. L. DRUMM, D. MARKAKIS, W. B. GUGGINO, P. L. ZEITLIN, AND B. J. CARTER. 1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268: 3781-3790.
27. 27. FLOTTE, T. R., S. A. AFIONE, AND P. L. ZEITLIN. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11: 517-521.
28. 28. FLOTTE, T. R., X. BARRAZA-ORTIZ, R. SOLOW, S. A. AFIONE, B. J. CARTER, AND W. B. GUGGINO. 1995. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2: 29-37.
29. 29. FLOTTE, T. R., AND B. J. CARTER. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2: 357-362. [Review]
30. 30. FRIEDMAN, T. 1996. Human gene therapy - An immature genie, but certainly out of the bottle. Nat. Med. 2: 144-147.
31. 31. GIRAUD, C., E. WINOCOUR, AND K. I. BERNS. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69: 6917-6924.
32. 32. GOODMAN, S., X. XIAO, R. E. DONAHUE, A. MOULTON, J. MILLER, C. WALSH, N. S. YOUNG, R. J. SAMULSKI, AND A. W. NIENHUIS. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492-500. [Published erratum appears in Blood, 1995, 85(3): 862]
33. 33. GROSSMAN, Z., E. MENDELSON, F. BROK-SIMONI, F. MILEGUIR, Y. LEITNER, G. RECHAVI, AND B. RAMOT. 1992. Detection of adeno-associated virus type 2 in human peripheral blood cells. J. Gen. Virol. 73: 961-966.
34. 34. HERMONAT, P. L., AND N. MUZYCZKA. 1984. Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81: 6466-6470.
35. 35. HOLSCHER, C., M. HORER, J. A. KLEINSCHMIDT, H. ZENTGRAF, A. BURKLE, AND R. HEILBRONN. 1994. Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: Requirements for productive replication of rep-negative AAV mutants. J. Virol. 68: 7169-7177.
36. 36. HOLSCHER, C., J. A. KLEINSCHMIDT, AND A. BURKLE. 1995. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant. J. Virol. 69: 6880-6885.
37. 37. KAPLITT, M. G., P. LEONE, R. J. SAMULSKI, X. XIAO, D. W. PFAFF, K. L. O'MALLEY, AND M. J. DURING. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8: 148-154.
38. 38. KAPLITT, M. G., X. XIAO, R. J. SAMULSKI, J. LI, K. OJAMMA, I. KLEIN, H. MAKIMURA, M. J. KAPLITT, R. K. STRUMPF, J. L. BRESLOW, AND E. B. DIETHRICH. 1996. Long term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann. Thoracic Surg. 62: 1669-1676.
39. 39. KEIR, S. D., C. BRANDOLI, J. R. WRATHALL, I. MOCCHETTI, R. J. SAMULSKI, J. LI, X. XIAO, AND C. TORNATORE. 1996. Gene transfer and expression in normal and injured spinal cord from an adeno-associated virus (AAV) vector. Soc. Neurosci. Abstr. 843.10.
40. 40. KOTIN, R. M., M. SINISCALCO, R. J. SAMULSKI, X. D. ZHU, L. HUNTER, C. A. LAUGHLIN, S. MCLAUGHLIN, N. MUZYCZKA, M. ROCCHI, AND K. I. BERNS. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87: 2211-2215.
41. 41. LABOW, M. A., L. H. GRAF JR., AND K. I. BERNS. 1987. Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol. Cell. Biol. 7: 1320-1325.
42. 42. MCCOWN, T. J., X. XIAO, J. LI, G. R. BREESE, AND R. J. SAMULSKI. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713: 99-107.
43. 43. MCLAUGHLIN, S. K., P. COLLIS, P. L. HERMONAT, AND N. MUZYCZKA. 1988. Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62: 1963-1973.
44. 44. MILLER, J. L., R. E. DONAHUE, S. E. SELLERS, R. J. SAMULSKI, N. S. YOUNG, AND A. W. NIENHUIS. 1994. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91: 10183-10187. [Published erratum appears in Proc. Natl. Acad. Sci. USA, 1995, 92(2): 646]
45. 45. MUZYCZKA, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158: 97-129. [Review]
46. 46. NAVIAUX, R. K., AND I. M. VERMA. 1992. Retroviral vectors for persistent expression in vivo. Curr. Opinion Biotechnol. 3: 540-547. [Review]
47. 47. PEEL, A. L., S. ZOLOTUKHIN, G. W. SCHRIMSHER, N. MUZYCZKA, AND P. J. REIER 1996. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell-type specific promoters. Submitted for publication.
48. 48. PHILIP, R., E. BRUNETTE, L. KILINSKI, D. MURUGESH, M. A. MCNALLY, K. UCAR, J. ROSENBLATT, T. B. OKARMA, AND J. S. LEBKOWSKI. 1994. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol. 14: 2411-2418.
49. 49. PODSAKOFF, G., K. K. WONG JR., AND S. CHATTERJEE. 1994. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68: 5656-5666.
50. 50. RUSSELL, D. W., I. E. ALEXANDER, AND A. D. MILLER 1995. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92: 5719-5723.
51. 51. RUSSELL, D. W., A. D. MILLER, AND I. E. ALEXANDER. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91: 8915-8919.
52. 52. SAMULSKI, R. J. 1993. Adeno-associated virus: Integration at a specific chromosomal locus. Curr. Opinion Genet. Dev. 3: 74-80. [Review]
53. 53. SAMULSKI, R. J., L. S. CHANG, AND T. SHENK. 1989. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63: 3822-3828.
54. 54. SAMULSKI, R. J., X. ZHU, X. XIAO, J. D. BROOK, D. E. HOUSMAN, N. EPSTEIN, AND L. A. HUNTER 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10: 3941-3950. [Published erratum appears in EMBO J., 1992, 11(3): 1228]
55. 55. SCHLEHOFER, J. R., M. EHRBAR, AND H. ZUR HAUSEN. 1986. Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helper virus dependent parvovirus. Virology 152: 110-117.
56. 56. SCHWARTZ, B., C. BENOIST, B. ABDALLAH, R. RANGARA, A. HASSAN, D. SCHERMAN, AND B. A. DEMENEIX. 1996. Gene transfer by naked DNA into adult mouse brain. Gene Ther. 3: 405-411.
57. 57. SHELLING, A. N., AND M. G. SMITH. 1994. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 1: 165-169.
58. 58. SNYDER, R., X. XIAO, AND R. J. SAMULSKI. 1996. Production of recombinant adeno-associated viral vectors. Pages 12.1.1-12.2.23 in N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Seidman, and J. S. Seidman, Eds., Current Protocols in Human Genetics. Wiley, New York.
59. 59. TAMAYOSE, K., Y. HIRAI, AND T. SHIMADA. 1996. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromotography. Hum. Gene Ther. 7: 507-513.
60. 60. TRATSCHIN, J. D., I. L. MILLER, M. G. SMITH, AND B. J. CARTER. 1985. Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol. Cell. Biol. 5: 3251-3260.
61. 61. VIEWEG, J., D. BOCZKOWSKI, K. M. ROBERSON, D. W. EDWARDS, M. PHILIP, R. PHILIP, T. RUDOLL, C. SMITH, C. ROBERTSON, AND E. GILBOA. 1995. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Res. 55: 2366-2372.
62. 62. WALSH, C. E., J. M. LIU, X. XIAO, N. S. YOUNG, A. W. NIENHUIS, AND R. J. SAMULSKI. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89: 7257-7261.
63. 63. WEITZMAN, M. D., S. R. KYOSTIO, R. M. KOTIN, AND R. A. OWENS. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91: 5808-5812.
64. 64. WOLFF, J. A., R. W. MALONE, P. WILLIAMS, W. CHONG, G. ACSADI, A. JANI, AND P. L. FELGNER 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
65. 65. Wu, P., C. M. DE FIEBRE, W. J. MILLARD, M. A. KING, S. WANG, S. O. BRYANT, Y. P. GAO, E. J. MARTIN, AND E. M. MEYER 1996. An AAV promoter-driven neuropeptide Y gene delivery system using Sendai virosomes for neurons and rat brain. Gene Ther. 3: 246-253.
66. 66. XIAO, X., W. DEVLAMINICK, AND J. MONAHAN. 1993. Adeno-associated virus (AAV) vectors for gene transfer. Adv. Drug Deliv. Rev. 12: 201-215.
67. 67. XIAO, X., J. LI, AND R. J. SAMULSKI. 1996. Long-term and efficient in vivo gene transfer into muscle tissue of immunocompetent mice with an rAAV vector. J. Virol., 70: 8098-8108.
68. 68. XIAO, X., T. J. MCCOWN, J. LI, G. R. BREESE, A. L. MORROW, AND R. J. SAMULSKI. 1997. Generation of animal model for seizure disorders using gene delivery by adeno-associated virus (AAV) vectors. Brain Res. in press.
69. 69. XIAO, X., W. XIAO, J. LI, AND R. J. SAMULSKI. 1997. A novel 165 base-pair terminal repeat is the only cis-element required for adeno-associated virus life cycle. Submitted for publication.
70. 70. YAKINOGLU, A. O., R. HEILBRONN, A. BURKLE, J. R. SCHLEHOFER, AND H. ZUR HAUSEN. 1988. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 48: 3123-3129.
71. 71. YAKOBSON, B., T. A. HRYNKO, M. J. PEAK, AND E. WINOCOUR 1989. Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J. Virol. 63: 1023-1030.
72. 72. YAKOBSON, B., T. KOCH, AND E. WINOCOUR 1987. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61: 972-981.
73. 73. YALKINOGLU, A. O., H. ZENTGRAF, AND U. HUBSCHER 1991. Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification. J. Virol. 65: 3175-3184.
74. 74. YANG, Q., F. CHEN, AND J. P. TREMPE. 1994. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68: 4847-4856.
75. 75. YANG, Y., K. GREENOUGH, AND J. M. WILSON. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3: 412-420.
76. 76. YANG, Y., Q. LI, H. C. ERTL, AND J. M. WILSON. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.
77. 77. YANG, Y., F. A. NUNES, K. BERENCSI, E. E. FURTH, E. GONCZOL, AND J. M. WILSON. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.
78. 78. YANG, Y., AND J. M. WILSON. 1995. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155: 2564-2570.
79. 79. ZHOU, S. Z., Q. LI, G. STAMATOYANNOPOULOS, AND A. SRIVASTAVA. 1996. Adeno-associated 2-mediated transduction and erythroid cell-specific expression of a human β-globin gene. Gene Ther. 3: 223-229.
80. 80. ZHOU, X., AND N. MUZYCZKA. 1996. An in vitro packaging system of adeno-associated virus. Submitted for publication.
81. 81. ZOLOTUKHIN, S., M. POTTER, W. W. HAUSWIRTH, J. GUY, AND N. MUZYCZKA. 1996. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70: 4646-4654.